Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 555-06-6
2. Aminobenzoate Sodium
3. 4-aminobenzoic Acid Sodium Salt
4. Sodium P-aminobenzoate
5. Sodium Aminobenzoate
6. Antergyl
7. Benzoic Acid, 4-amino-, Monosodium Salt
8. Sodium;4-aminobenzoate
9. Sodium Para-aminobenzoate
10. Benzoic Acid, P-amino-, Monosodium Salt
11. 4-aminobenzoic Acid Sodium
12. 75ui7quz5j
13. 4-aminobenzoic Acid, Sodium Salt
14. Pabavit
15. Monosodium 4-aminobenzoate
16. Chembl1762658
17. Sodium4-aminobenzoate
18. P-aminobenzoic Acid, Sodium Salt
19. Einecs 209-080-3
20. Unii-75ui7quz5j
21. Ai3-16691
22. Mfcd00064395
23. Benzoic Acid, 4-amino-, Sodium Salt
24. Sodium 4-azanylbenzoate
25. Ec 209-080-3
26. Aminobenzoate Sodium (usp)
27. Schembl587865
28. 4-aminobenzoic Acid Sodium Sal
29. Dtxsid8060296
30. 4-aminobenzoicacidsodiumsalt
31. Benzoic Acid, P-amino-, Sodium Salt
32. Sodium Aminobenzoate [mart.]
33. Aminobenzoate Sodium [usp-rs]
34. Sodium Aminobenzoate [who-dd]
35. Akos003051697
36. Akos015888388
37. Akos015950610
38. Akos024272189
39. 54287-22-8
40. As-57673
41. Aminobenzoate Sodium [usp Impurity]
42. Aminobenzoate Sodium [usp Monograph]
43. Db-052748
44. A0276
45. Ft-0617562
46. Benzoic Acid, 4-amino-, Sodium Salt (1:1)
47. D02907
48. O12079
49. A830682
50. W-105558
51. Q27266411
| Molecular Weight | 159.12 g/mol |
|---|---|
| Molecular Formula | C7H6NNaO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 159.02962272 g/mol |
| Monoisotopic Mass | 159.02962272 g/mol |
| Topological Polar Surface Area | 66.2 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 132 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Sodium 4-Aminobenzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium 4-Aminobenzoate, including repackagers and relabelers. The FDA regulates Sodium 4-Aminobenzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium 4-Aminobenzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium 4-Aminobenzoate supplier is an individual or a company that provides Sodium 4-Aminobenzoate active pharmaceutical ingredient (API) or Sodium 4-Aminobenzoate finished formulations upon request. The Sodium 4-Aminobenzoate suppliers may include Sodium 4-Aminobenzoate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium 4-Aminobenzoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium 4-Aminobenzoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium 4-Aminobenzoate active pharmaceutical ingredient (API) in detail. Different forms of Sodium 4-Aminobenzoate DMFs exist exist since differing nations have different regulations, such as Sodium 4-Aminobenzoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium 4-Aminobenzoate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium 4-Aminobenzoate USDMF includes data on Sodium 4-Aminobenzoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium 4-Aminobenzoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium 4-Aminobenzoate suppliers with USDMF on PharmaCompass.
Sodium 4-Aminobenzoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium 4-Aminobenzoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium 4-Aminobenzoate GMP manufacturer or Sodium 4-Aminobenzoate GMP API supplier for your needs.
A Sodium 4-Aminobenzoate CoA (Certificate of Analysis) is a formal document that attests to Sodium 4-Aminobenzoate's compliance with Sodium 4-Aminobenzoate specifications and serves as a tool for batch-level quality control.
Sodium 4-Aminobenzoate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium 4-Aminobenzoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium 4-Aminobenzoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium 4-Aminobenzoate EP), Sodium 4-Aminobenzoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium 4-Aminobenzoate USP).
LOOKING FOR A SUPPLIER?
